These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
796 related items for PubMed ID: 18644063
1. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Pickup JC, Sutton AJ. Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063 [Abstract] [Full Text] [Related]
2. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A. Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459 [Abstract] [Full Text] [Related]
4. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Sulli N, Shashaj B. Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629 [Abstract] [Full Text] [Related]
6. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone. Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA. Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290 [Abstract] [Full Text] [Related]
13. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, Heine RJ. Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173 [Abstract] [Full Text] [Related]
14. Prevalence and associations of psychological distress in young adults with Type 1 diabetes. Hislop AL, Fegan PG, Schlaeppi MJ, Duck M, Yeap BB. Diabet Med; 2008 Jan; 25(1):91-6. PubMed ID: 18199136 [Abstract] [Full Text] [Related]
15. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel. Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116 [Abstract] [Full Text] [Related]
16. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients. Lepore G, Bruttomesso D, Bonomo M, Dodesini AR, Costa S, Meneghini E, Corsi A, Nosari I, Trevisan R. Diabet Med; 2009 Jun; 26(6):602-8. PubMed ID: 19538235 [Abstract] [Full Text] [Related]
19. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system. Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L. Adv Med Sci; 2006 Jun; 51():133-6. PubMed ID: 17357293 [Abstract] [Full Text] [Related]
20. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus]. Hasselmann C, Bonnemaison E, Faure N, Mercat I, Bouillo Pépin-Donat M, Magontier N, Chantepie A, Labarthe F. Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]